ℹ️
🇬🇧
Search
Search for publications relevant for "RAS wild-type"
RAS wild-type
Publication
Class
Person
Publication
Programmes
Export current view
publication
Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers
2021 |
Publication without faculty affiliation
publication
Options and rationale for reinstituting anti-EGFR therapy in pretreated RAS wild-type advanced colorectal carcinomas
2023 |
Publication without faculty affiliation
publication
Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis
2022 |
Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach
2022 |
Publication without faculty affiliation
publication
Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions
2020 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine
publication
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC
2019 |
First Faculty of Medicine
publication
Patient with metastatic colorectal cancer treated in the third line of therapy with trifluridin/tipiracil
2018 |
First Faculty of Medicine
publication
Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature
2022 |
Faculty of Medicine in Pilsen
publication
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
2015 |
Publication without faculty affiliation
publication
Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis
2018 |
Faculty of Medicine in Pilsen, First Faculty of Medicine